Cell Therapies Pty. Ltd. is a CDMO specializing in advanced cell-based therapies for the global market. Established in 2003, we are a leading cGMP-compliant manufacturer of cell therapies, gene therapies, cellular immunotherapies, and regenerative medicine products. Our 13-cleanroom cGMP facility meets global regulatory and ISO standards, benchmarked by PIC/S. We offer comprehensive manufacturing services from development to deployment, ensuring needle-to-needle control with clinical integration. Co-located with the Peter MacCallum Cancer Centre in Melbourne, Australia, we have access to hospitals, research institutes, and universities, facilitating product development, clinical translation, and patient access.